Iran war. Companies don't want their ships to go back23 Jun 2026 14:04
To the Persian Gulf as are worried they would get stuck again. I was thinking oil Companies may want to hire Iranian ships, but what if they fall out with the USA again?? Saudi and the rest had better get building those new pipelines to avoid the strait!!!!!!!!!!!!!!!!
As a shareholder apart from the FDA application I would like23 Jun 2026 12:53
The sales side strengthened. Ideally with one new director to drive sales in the EU forward. We may also need sales person to drive sales in the USA forward, once we have the FDA approval. 2 months after the application has gone in they should be looking. FDA approval will happen.
Up 7.14%. Results presentation has revealed the Royal Marsden23 Jun 2026 11:23
RNS a few months ago aims to see if lung cancer patients who's CtDna reveals nothing would benefit from the DNA analysis of the CTC's. Clearly this is strongly suspected. If so a national roll out in the NHS, and then the whole World is possible. That would be a few quid.
RE: Results presentation. NHS National rollout? Existing collaboration23 Jun 2026 10:29
Up 7%. The 20% dive in the sp was totally unjustified IMHO. The presentation is being seen and now the pennies have dropped.
Back to 2p plus soon IMHO.
====================
If the lung cancer CTC test the Royal Marsden is looking at is adopted by the UK's NHS then there is always the rest of the entire World to follow suit!!!!!
Put the in your pipe and smoke it, as the saying goes.
RE: Results presentation. NHS National rollout? Existing collaboration23 Jun 2026 10:21
With the UK's NHS aiming to obtain information from existing lung cancer patients (where not available from CtDna) to guide treatment. It appears this is what the Royal Marsden RNS was all about a few months ago. Using parsortix to catch the CTC's they can be analysed to point to the best treatment! So potentially a UK national roll out for this service. I remember representatives of the uk's NHS visited Cellbxhealth last I think September. This has moved on quite quickly it seems so the experts clearly think this approach could be implemented nationwide. Also Grail must be aware of this deal as they financed testing the CtDna of lung patients which fell short of expectations.......................... hmmmmmmmmm!!!!
=============================
If this Lung cancer CTC test gets the cancer information the Grail CtDna test was missing then Grail will be rather interested I would have thought! The Royal Marsden is looking into this NOW..........
Results presentation. NHS National rollout? Existing collaboration23 Jun 2026 10:12
With the UK's NHS aiming to obtain information from existing lung cancer patients (where not available from CtDna) to guide treatment. It appears this is what the Royal Marsden RNS was all about a few months ago. Using parsortix to catch the CTC's they can be analysed to point to the best treatment! So potentially a UK national roll out for this service. I remember representatives of the uk's NHS visited Cellbxhealth last I think September. This has moved on quite quickly it seems so the experts clearly think this approach could be implemented nationwide. Also Grail must be aware of this deal as they financed testing the CtDna of lung patients which fell short of expectations.......................... hmmmmmmmmm!!!!